Bonraybio Co (TPE:6955) EBITDA Margin % : 35.79% (As of Jun. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Bonraybio Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Bonraybio Co's EBITDA for the three months ended in Jun. 2024 was NT$36.8 Mil. Bonraybio Co's Revenue for the three months ended in Jun. 2024 was NT$102.8 Mil. Therefore, Bonraybio Co's EBITDA margin for the quarter that ended in Jun. 2024 was 35.79%.

Bonraybio Co EBITDA Margin % Historical Data

The historical data trend for Bonraybio Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bonraybio Co EBITDA Margin % Chart

Bonraybio Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

-107.26

-35.93

10.70

22.93

Bonraybio Co Quarterly Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBITDA Margin %	Get a 7-Day Free Trial			3.41	15.68	17.79	26.37	35.79

Competitive Comparison of Bonraybio Co's EBITDA Margin %

For the Medical Devices subindustry, Bonraybio Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bonraybio Co's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonraybio Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Bonraybio Co's EBITDA Margin % falls into.

Bonraybio Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Bonraybio Co's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	36.611	/	159.641
	=	22.93 %

Bonraybio Co's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %	=	EBITDA (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	36.793	/	102.803
	=	35.79 %

Bonraybio Co (TPE:6955) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Bonraybio Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Bonraybio Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bonraybio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bonraybio Co Ltd (TPE:6955) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 118, Gongye 9th Road, 4th Floor, Dali District, Taichung City, TWN

Website

http://www.bonraybio.com

Bonraybio Co Ltd engages in research, development, and manufacturing of vitro diagnostic devices. The firm produces semen quality analyzers and Semen Analysis Systems for the clinic.

Bonraybio Co Headlines

No Headlines